Facebook Pixel Drug's gift of extra years | Daily Mirror UK - newspaper - Bu hikayeyi Magzter.com'da okuyun

Denemek ALTIN - Özgür

Drug's gift of extra years

Daily Mirror UK

|

May 31, 2025

A DRUG that turbocharges the immune system could double the survival time for patients with newly diagnosed head and neck cancers.

- BY HANNA GEISSLER

A trial in 24 countries found that people taking pembrolizumab, alongside surgery and radiotherapy, remained cancer-free for an average of five years.

Daily Mirror UK'den DAHA FAZLA HİKAYE

Listen

Translate

Share

-
+

Change font size